Next Article in Journal
Evaluation of the Cytotoxic, Anti-Inflammatory, and Immunomodulatory Effects of Withaferin A (WA) against Lipopolysaccharide (LPS)-Induced Inflammation in Immune Cells Derived from BALB/c Mice
Next Article in Special Issue
The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates
Previous Article in Journal
Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment
Previous Article in Special Issue
Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(6), 1257; https://doi.org/10.3390/pharmaceutics14061257
Action Date Notes Link
article xml file uploaded 13 June 2022 12:59 CEST Original file -
article xml uploaded. 13 June 2022 12:59 CEST Update https://www.mdpi.com/1999-4923/14/6/1257/xml
article pdf uploaded. 13 June 2022 12:59 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1257/pdf
article supplementary file uploaded. 13 June 2022 12:59 CEST - https://www.mdpi.com/1999-4923/14/6/1257#supplementary
article html file updated 13 June 2022 13:00 CEST Original file -
article html file updated 13 June 2022 13:01 CEST Update -
article html file updated 12 August 2022 20:07 CEST Update https://www.mdpi.com/1999-4923/14/6/1257/html
Back to TopTop